Near-infrared (NIR) fluorescent agent for in vivo imaging and other applications.
For laboratory use only. This product is intended for animal research only and not for use in humans.
BombesinRSense™ 680 targeted near infrared (NIR) fluorescent imaging agent is specific for bombesin receptors (BBRs) expressed in many types of cancer. Bombesin-like peptides and their G-protein coupled receptors have been shown to play a role in cancer and are overexpressed in a variety of tumors, including prostate, breast, lung, CNS, gastric, colon, and renal cell carcinomas.
BombesinRSense 680 comprises a 7-amino acid bombesin peptide analog, an NIR fluorophore (ex/em 665/691 nm) and a pharmacokinetic modifier to improve its plasma availability (plasma t1/2 = 30-45 min). This agent can be used to target and quantify upregulation of bombesin receptors (BBR) in vivo associated with tumor proliferation.
|产品尺寸||1 Vial (10 doses)|
BombesinRSense 680 in vivo fluorescent imaging agent protocol
BombesinRSense™680 is a fluorescently-labeled peptide designed to bind to bombesin receptors involved in cancer cell stimulation of proliferation.